Brucke Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
CIM
ATO
Brucke Financial's GILD Position: Q2 2026 in Review
Brucke Financial reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $5.93K and leaving 2,463 shares worth $311K. The position accounts for 0.14% of the portfolio, ranked #116.
Brucke Financial first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $422K in Q3 2025. 879 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Brucke Financial held 2,463 shares of Gilead Sciences worth $311K as of Q2 2026.
- Brucke Financial sold 45 Gilead Sciences shares in Q2 2026, an estimated $5.93K.
- Gilead Sciences made up 0.14% of Brucke Financial's portfolio in Q2 2026, its #116 holding.
- Brucke Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
- Brucke Financial's Gilead Sciences position peaked at $422K in Q3 2025.
- 879 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Brucke Financial's 13F filing for Q2 2026, filed 21 Jul 2026.